17-beta-estradiol eluting stent versus phosphorylcholine-coated Stent for the treatment of native coronary artery disease
17-beta-estradiol eluting stent versus phosphorylcholine-coated Stent for the treatment of native coronary artery disease
复制标题
DOI:
10.1016/j.amjcard.2005.04.040
复制
发表时间:
2005-09-01
影响因子:
2.8
通讯作者:
Colombo, A
中科院分区:
文献类型:
--
作者:
Airoldi, F;Di Mario, C;Colombo, A
In this study we randomly compared the estradiol Outing stent (17-beta-E) with phosphorylcholine (PC)-coated stents in native coronary arteries. The incidence of angiographic restenosis was 23% in the 17-beta-E group and 31% in the PC group (p = 0.34). The major adverse cardiovascular event rates were also similar in the 2 groups (17% in the 17-beta-E group vs 22% in the PC group, p = 0.47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-beta-E eluting stent over the control PC stent. (c) 2005 Elsevier Inc. All rights reserved.